Concepedia

Andrew J. Rech

AJ

25

Publications

6.2K

Citations

22

H-Index

2009

Active since

Affiliations

University of Pennsylvania(Current)

Parker Institute for Cancer Immunotherapy

Cancer Research Institute

Translational Therapeutics (United States)

UPMC Hillman Cancer Center

Andrew J. Rech is an author at University of Pennsylvania specializing in medicine, immunology, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2009–2025

25

Publications

25

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

Christina Twyman-Saint Victor, Andrew J. Rech, Amit Maity et al. · Nature · 2015 · 2.3K citations · Full text

, , +9

Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy

Jinyang Li, Katelyn T. Byrne, Fangxue Yan et al. · Immunity · 2018 · 721 citations · Full text

, , +11

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

Daniel K. Wells, Marit M. van Buuren, Kristen K. Dang et al. · Cell · 2020 · 507 citations · Full text

, , +12

PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial

Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung et al. · Nature Medicine · 2022 · 455 citations · Full text

, , +6

CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients

Andrew J. Rech, Rosemarie Mick, Sunil Martin et al. · Science Translational Medicine · 2012 · 325 citations

Rows per page

1–5 of 25